Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001213900-23-037838
Filing Date
2023-05-10
Accepted
2023-05-09 21:46:08
Documents
18
Period of Report
2023-05-09

Document Format Files

Seq Description Document Type Size
1 PRELIMINARY PROXY STATEMENT ea178008-pre14a_180lifesci.htm PRE 14A 1198773
2 GRAPHIC img_001.jpg GRAPHIC 10370
3 GRAPHIC img_002.jpg GRAPHIC 11611
4 GRAPHIC img_003.jpg GRAPHIC 11812
5 GRAPHIC img_004.jpg GRAPHIC 9857
6 GRAPHIC img_005.jpg GRAPHIC 10402
7 GRAPHIC img_006.jpg GRAPHIC 11050
8 GRAPHIC img_007.jpg GRAPHIC 11493
9 GRAPHIC img_008.jpg GRAPHIC 9849
10 GRAPHIC img_009.jpg GRAPHIC 9774
11 GRAPHIC img_010.jpg GRAPHIC 9855
12 GRAPHIC img_011.jpg GRAPHIC 75818
13 GRAPHIC img_012.jpg GRAPHIC 72741
14 GRAPHIC img_013.jpg GRAPHIC 10080
15 GRAPHIC img_014.jpg GRAPHIC 1991
16 GRAPHIC img_015.jpg GRAPHIC 1561
17 GRAPHIC img_016.jpg GRAPHIC 1405
18 GRAPHIC img_017.jpg GRAPHIC 2147
  Complete submission text file 0001213900-23-037838.txt   1576537
Mailing Address 3000 EL CAMINO REAL BLDG 4, STE 200 PALO ALTO CA 94306
Business Address 3000 EL CAMINO REAL BLDG 4, STE 200 PALO ALTO CA 94306 650-507-0669
180 Life Sciences Corp. (Filer) CIK: 0001690080 (see all company filings)

EIN.: 813832378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-38105 | Film No.: 23904087
SIC: 2834 Pharmaceutical Preparations